These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9226307)

  • 1. Why is female sex an independent predictor of shortened overall survival after proton/photon radiation therapy for skull base chordomas?
    Halperin EC
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):225-30. PubMed ID: 9226307
    [No Abstract]   [Full Text] [Related]  

  • 2. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure.
    Noël G; Habrand JL; Jauffret E; de Crevoisier R; Dederke S; Mammar H; Haie-Méder C; Pontvert D; Hasboun D; Ferrand R; Boisserie G; Beaudré A; Gaboriaud G; Guedea F; Petriz L; Mazeron JJ
    Strahlenther Onkol; 2003 Apr; 179(4):241-8. PubMed ID: 12707713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
    Hug EB; Slater JD
    Neurosurg Clin N Am; 2000 Oct; 11(4):627-38. PubMed ID: 11082173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skull base chordomas: clinical outcome in a consecutive series of 45 patients with long-term follow-up and evaluation of clinical and biological prognostic factors.
    Boari N; Gagliardi F; Cavalli A; Gemma M; Ferrari L; Riva P; Mortini P
    J Neurosurg; 2016 Aug; 125(2):450-60. PubMed ID: 26745472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protonthérapie D'Orsay experience.
    Noël G; Habrand JL; Mammar H; Pontvert D; Haie-Méder C; Hasboun D; Moisson P; Ferrand R; Beaudré A; Boisserie G; Gaboriaud G; Mazal A; Kérody K; Schlienger M; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):392-8. PubMed ID: 11567813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomas.
    Mercado CE; Holtzman AL; Rotondo R; Rutenberg MS; Mendenhall WM
    Head Neck; 2019 Feb; 41(2):536-541. PubMed ID: 30537295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas.
    Bugoci DM; Girvigian MR; Chen JC; Miller MM; Rahimian J
    Am J Clin Oncol; 2013 Aug; 36(4):404-10. PubMed ID: 22772429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
    Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases.
    Hoch BL; Nielsen GP; Liebsch NJ; Rosenberg AE
    Am J Surg Pathol; 2006 Jul; 30(7):811-8. PubMed ID: 16819322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of skull base chordomas: prognostic factors and long-term results of proton-beam radiotherapy.
    Hug EB
    Neurosurg Focus; 2001 Mar; 10(3):E11. PubMed ID: 16734403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chordomas of the craniocervical junction: follow-up review and prognostic factors.
    Colli B; Al-Mefty O
    J Neurosurg; 2001 Dec; 95(6):933-43. PubMed ID: 11765837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endonasal Endoscopic Resection and Radiotherapy in Skull Base Chordomas.
    Zhang HK; Sun XC; Hu L; Wang JJ; Wang DH
    J Craniofac Surg; 2016 Oct; 27(7):e709-e713. PubMed ID: 27564072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull.
    Santoni R; Liebsch N; Finkelstein DM; Hug E; Hanssens P; Goitein M; Smith AR; O'Farrell D; Efird JT; Fullerton B; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):59-68. PubMed ID: 9588918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chordoma].
    George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
    Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cytogenetic abnormalities on the management of skull base chordomas.
    Almefty KK; Pravdenkova S; Sawyer J; Al-Mefty O
    J Neurosurg; 2009 Apr; 110(4):715-24. PubMed ID: 19133754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma.
    Terahara A; Niemierko A; Goitein M; Finkelstein D; Hug E; Liebsch N; O'Farrell D; Lyons S; Munzenrider J
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):351-8. PubMed ID: 10487555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton beam therapy for skull base chordomas in 106 patients: A dose adaptive radiation protocol.
    Fung V; Calugaru V; Bolle S; Mammar H; Alapetite C; Maingon P; De Marzi L; Froelich S; Habrand JL; Dendale R; Noël G; Feuvret L
    Radiother Oncol; 2018 Aug; 128(2):198-202. PubMed ID: 29310903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male sex as a risk factor for the clinical course of skull base chordomas.
    Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
    J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.